pantoprazole has been researched along with prednisone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ra, A; Tobe, SW | 1 |
| Bartsch, R; Drach, J; Hejna, M; Raderer, M; Wöhrer, S | 1 |
| Kimel, G; Ricketson, J; Spence, J; Weir, R | 1 |
| Heim, M; Kim, MJ; Mayr, M | 1 |
| Burmeister, J; Diener, HC; Holle, D; Obermann, M; Ose, C; Scherag, A | 1 |
| Chen, E; Evans, A; Hansen, AR; Joshua, AM; Knox, J; Prawira, A; Sridhar, SS; Tan, S; Tannock, IF; Templeton, A; Vera-Badillo, F; Wang, L; Wouters, BG | 1 |
1 review(s) available for pantoprazole and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pantoprazole and prednisone
| Article | Year |
|---|---|
Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic c
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Cluster Headache; Double-Blind Method; Follow-Up Studies; Humans; Pain Measurement; Pantoprazole; Prednisone; Treatment Outcome | 2013 |
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Pantoprazole; Prednisone; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life | 2019 |
9 other study(ies) available for pantoprazole and prednisone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; Biopsy; Ciprofloxacin; Creatinine; Female; Gastroesophageal Reflux; Humans; Kidney; Nephritis, Interstitial; Oliguria; Omeprazole; Pantoprazole; Prednisone; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Time Factors | 2004 |
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Mitoxantrone; Neoplasm Staging; Omeprazole; Pantoprazole; Patient Compliance; Prednisone; Proton Pump Inhibitors; Rituximab; Stomach Neoplasms; Sulfoxides; Treatment Outcome; Vincristine | 2005 |
Acute allergic interstitial nephritis after use of pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Anti-Ulcer Agents; Drug Hypersensitivity; Humans; Male; Middle Aged; Nephritis, Interstitial; Pantoprazole; Prednisone | 2009 |
Effect of corticosteroids during ongoing drug exposure in pantoprazole-induced interstitial nephritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Humans; Male; Nephritis, Interstitial; Pantoprazole; Prednisone; Proton Pump Inhibitors | 2010 |